MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target

Yifei Wang(Prince of Wales Hospital), Wei Kang(National Institutes of Health)

Theranostics

January 1, 2022

10.7150/thno.75431

Cited by 41

Related Papers

Modular enzyme assembly for enhanced cascade biocatalysis and metabolic flux

|Nature Communications|2019|284

Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis

|Clinical Cancer Research|2011|258

Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma

|Molecular Cancer|2015|130

FGF18–FGFR2 signaling triggers the activation of c-Jun–YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential

|Oncogene|2020|42

MCM7 serves as a prognostic marker in diffuse-type gastric adenocarcinoma and siRNA-mediated knockdown suppresses its oncogenic function

|Oncology Reports|2014|24